Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces

Nat Commun. 2021 Nov 9;12(1):6470. doi: 10.1038/s41467-021-26579-z.

Abstract

Antibody-Framework-to-Antigen Distance (AFAD) - the distance between the body of an antibody and a protein antigen - is an important parameter governing antibody recognition. Here, we quantify AFAD for ~2,000 non-redundant antibody-protein-antigen complexes in the Protein Data Bank. AFADs showed a gaussian distribution with mean of 16.3 Å and standard deviation (σ) of 2.4 Å. Notably, antibody-antigen complexes with extended AFADs (>3σ) were exclusively human immunodeficiency virus-type 1 (HIV-1)-neutralizing antibodies. High correlation (R2 = 0.8110) was observed between AFADs and glycan coverage, as assessed by molecular dynamics simulations of the HIV-1-envelope trimer. Especially long AFADs were observed for antibodies targeting the glycosylated trimer apex, and we tested the impact of introducing an apex-glycan hole (N160K); the cryo-EM structure of the glycan hole-targeting HIV-1-neutralizing antibody 2909 in complex with an N160K-envelope trimer revealed a substantially shorter AFAD. Overall, extended AFADs exclusively recognized densely glycosylated surfaces, with the introduction of a glycan hole enabling closer recognition.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / immunology
  • Antibodies, Neutralizing / metabolism
  • Antigen-Antibody Complex / immunology*
  • Antigen-Antibody Complex / metabolism
  • Broadly Neutralizing Antibodies / immunology*
  • Epitopes / immunology
  • Epitopes / metabolism
  • HIV Antibodies / immunology*
  • HIV Infections / immunology
  • HIV Infections / metabolism
  • HIV-1 / immunology
  • HIV-1 / metabolism
  • Humans
  • Molecular Dynamics Simulation

Substances

  • Antibodies, Neutralizing
  • Antigen-Antibody Complex
  • Broadly Neutralizing Antibodies
  • Epitopes
  • HIV Antibodies